Search details
1.
Safety of Streptococcus pyogenes Vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post-Marketing Monitoring.
Clin Infect Dis
; 77(6): 917-924, 2023 09 18.
Article
in English
| MEDLINE | ID: mdl-37232372
2.
Fitting the reproduction number from UK coronavirus case data and why it is close to 1.
Philos Trans A Math Phys Eng Sci
; 380(2233): 20210301, 2022 Oct 03.
Article
in English
| MEDLINE | ID: mdl-35965470
3.
Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.
N Engl J Med
; 378(8): 719-730, 2018 02 22.
Article
in English
| MEDLINE | ID: mdl-29466164
4.
Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors.
Hum Vaccin
; 7(6): 639-45, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21508675
5.
Adolescent Tillaux Fractures: A Systematic Review of the Literature.
Cureus
; 13(1): e12860, 2021 Jan 22.
Article
in English
| MEDLINE | ID: mdl-33643731
6.
Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteers.
PLoS One
; 8(2): e55831, 2013.
Article
in English
| MEDLINE | ID: mdl-23418465
7.
Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adults.
Clin Vaccine Immunol
; 20(3): 397-408, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23345581
8.
A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.
PLoS One
; 7(8): e41936, 2012.
Article
in English
| MEDLINE | ID: mdl-22870265
9.
A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers.
AIDS Res Hum Retroviruses
; 25(11): 1107-16, 2009 Nov.
Article
in English
| MEDLINE | ID: mdl-19943789
Results
1 -
9
de 9
1
Next >
>>